Cargando…
The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy
BACKGROUND: Targeted axillary dissection (TAD), the combination of sentinel lymph node biopsy (SLNB) and targeted lymph node biopsy (TLNB), can reduce the false negative rates of sentinel node biopsy alone dramatically in breast cancer patients, who received neoadjuvant chemotherapy (NAC). However m...
Autores principales: | Reitsamer, R., Peintinger, F., Forsthuber, E., Sir, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050798/ https://www.ncbi.nlm.nih.gov/pubmed/33813230 http://dx.doi.org/10.1016/j.breast.2021.03.008 |
Ejemplares similares
-
Reply: Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Reitsamer, R, et al.
Publicado: (2005) -
Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients
por: Peintinger, F, et al.
Publicado: (2003) -
200 Sentinel lymph node biopsies without axillary lymph node dissection – no axillary recurrences after a 3-year follow-up
por: Reitsamer, R, et al.
Publicado: (2004) -
Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study
por: Martínez, María, et al.
Publicado: (2022) -
Marking Techniques for Targeted Axillary Dissection Among Patients
With Node-Positive Breast Cancer Treated With Neoadjuvant
Chemotherapy
por: Gante, Inês, et al.
Publicado: (2023)